Literature DB >> 30575422

Role of the cytoskeleton in the development of a hypofibrotic cardiac fibroblast phenotype in volume overload heart failure.

Rachel C Childers1,2,3, Ian Sunyecz1,2, T Aaron West2, Mary J Cismowski2, Pamela A Lucchesi2,4, Keith J Gooch1,3.   

Abstract

Hemodynamic load regulates cardiac remodeling. In contrast to pressure overload (increased afterload), hearts subjected to volume overload (VO; preload) undergo a distinct pattern of eccentric remodeling, chamber dilation, and decreased extracellular matrix content. Critical profibrotic roles of cardiac fibroblasts (CFs) in postinfarct remodeling and in response to pressure overload have been well established. Little is known about the CF phenotype in response to VO. The present study characterized the phenotype of primary cultures of CFs isolated from hearts subjected to 4 wk of VO induced by an aortocaval fistula. Compared with CFs isolated from sham hearts, VO CFs displayed a "hypofibrotic" phenotype, characterized by a ~50% decrease in the profibrotic phenotypic markers α-smooth muscle actin, connective tissue growth factor, and collagen type I, despite increased levels of profibrotic transforming growth factor-β1 and an intact canonical transforming growth factor-β signaling pathway. Actin filament dynamics were characterized, which regulate the CF phenotype in response to biomechanical signals. Actin polymerization was determined by the relative amounts of G-actin monomers versus F-actin. Compared with sham CFs, VO CFs displayed ~78% less F-actin and an increased G-actin-to-F-actin ratio (G/F ratio). In sham CFs, treatment with the Rho kinase inhibitor Y-27632 to increase the G/F ratio resulted in recapitulation of the hypofibrotic CF phenotype observed in VO CFs. Conversely, treatment of VO CFs with jasplakinolide to decrease the G/F ratio restored a more profibrotic response (>2.5-fold increase in α-smooth muscle actin, connective tissue growth factor, and collagen type I). NEW & NOTEWORTHY The present study is the first to describe a "hypofibrotic" phenotype of cardiac fibroblasts isolated from a volume overload model. Our results suggest that biomechanical regulation of actin microfilament stability and assembly is a critical mediator of cardiac fibroblast phenotypic modulation.

Entities:  

Keywords:  cardiac fibroblasts; actin cytoskeleton; fibrosis; heart failure; volume overload

Mesh:

Substances:

Year:  2018        PMID: 30575422     DOI: 10.1152/ajpheart.00095.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

Review 1.  Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural products.

Authors:  April L Risinger; Lin Du
Journal:  Nat Prod Rep       Date:  2019-11-25       Impact factor: 13.423

Review 2.  The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

3.  Loss of talin in cardiac fibroblasts results in augmented ventricular cardiomyocyte hypertrophy in response to pressure overload.

Authors:  Natalie A Noll; Lance A Riley; Christy S Moore; Lin Zhong; Mathew R Bersi; James D West; Roy Zent; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-25       Impact factor: 5.125

4.  In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan.

Authors:  Guillem Jorba; Joaquim Aguirre-Plans; Valentin Junet; Cristina Segú-Vergés; José Luis Ruiz; Albert Pujol; Narcís Fernández-Fuentes; José Manuel Mas; Baldo Oliva
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

5.  Ubiquitin Pathway Is Associated with Worsening Left Ventricle Function after Mitral Valve Repair: A Global Gene Expression Study.

Authors:  Feng-Chun Tsai; Gwo-Jyh Chang; Ying-Ju Lai; Shang-Hung Chang; Wei-Jan Chen; Yung-Hsin Yeh
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

Review 6.  Tubulin Post-translational Modifications: Potential Therapeutic Approaches to Heart Failure.

Authors:  Chang Liu; Yuwen Chen; Yao Xie; Meixiang Xiang
Journal:  Front Cell Dev Biol       Date:  2022-04-12

7.  Inhibition of Notch Signaling Alleviated Diabetic Macrovasculopathy in an In Vitro Model.

Authors:  Kuo-Li Pan; Yung-Chien Hsu; Chun-Wu Tung; Shih-Tai Chang; Chang-Min Chung; Chun-Liang Lin
Journal:  Acta Cardiol Sin       Date:  2020-09       Impact factor: 2.672

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.